These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 10895409

  • 1. Effect of adjunctive intracoronary adenosine on myocardial ischemia, hemodynamic function and left ventricular performance during percutaneous transluminal coronary angioplasty: clinical access to ischemic preconditioning?
    Heidland UE, Heintzen MP, Michel CJ, Strauer BE.
    Coron Artery Dis; 2000 Jul; 11(5):421-8. PubMed ID: 10895409
    [Abstract] [Full Text] [Related]

  • 2. Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosine.
    Heidland UE, Heintzen MP, Schwartzkopff B, Strauer BE.
    Am Heart J; 2000 Nov; 140(5):813-20. PubMed ID: 11054630
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE, Heidland UE, Heintzen MP, Schwartzkopff B.
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [Abstract] [Full Text] [Related]

  • 4. Intracoronary administration of dipyridamole prior to percutaneous transluminal coronary angioplasty provides a protective effect exceeding that of ischemic preconditioning.
    Heidland UE, Heintzen MP, Michel CJ, Strauer BE.
    Coron Artery Dis; 2000 Dec; 11(8):607-13. PubMed ID: 11107508
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
    Strauer BE, Heidland UE, Heintzen MP, Schwartzkopff B.
    J Am Coll Cardiol; 1996 Nov 01; 28(5):1119-26. PubMed ID: 8890804
    [Abstract] [Full Text] [Related]

  • 6. Preconditioning of human myocardium with adenosine during coronary angioplasty.
    Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R.
    Circulation; 1997 Jun 03; 95(11):2500-7. PubMed ID: 9184580
    [Abstract] [Full Text] [Related]

  • 7. The effects of intracoronary adenosine on preconditioning during coronary angioplasty.
    Kerensky RA, Kutcher MA, Braden GA, Applegate RJ, Solis GA, Little WC.
    Clin Cardiol; 1995 Feb 03; 18(2):91-6. PubMed ID: 7720296
    [Abstract] [Full Text] [Related]

  • 8. Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment?
    Billinger M, Fleisch M, Eberli FR, Garachemani A, Meier B, Seiler C.
    J Am Coll Cardiol; 1999 Mar 15; 33(4):1027-35. PubMed ID: 10091831
    [Abstract] [Full Text] [Related]

  • 9. Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans.
    Leesar MA, Stoddard MF, Xuan YT, Tang XL, Bolli R.
    J Am Coll Cardiol; 2003 Aug 06; 42(3):437-45. PubMed ID: 12906969
    [Abstract] [Full Text] [Related]

  • 10. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty.
    Leesar MA, Stoddard MF, Manchikalapudi S, Bolli R.
    J Am Coll Cardiol; 1999 Sep 06; 34(3):639-50. PubMed ID: 10483942
    [Abstract] [Full Text] [Related]

  • 11. Preconditioning the human myocardium with intracoronary adenosine.
    Mehta AB, Mardikar HM, Hiregouder NS, Sethi RB, Solanki DR.
    Indian Heart J; 1998 Sep 06; 50(4):397-401. PubMed ID: 9835198
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty.
    Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R.
    Circulation; 2001 Jun 19; 103(24):2935-41. PubMed ID: 11413083
    [Abstract] [Full Text] [Related]

  • 14. [Protection and "preconditioning" of the human heart during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole administration].
    Strauer BE, Heidland UE, Vogt M, Schwartzkopff B, Heintzen MP.
    Med Klin (Munich); 1995 Mar 01; 90(3):125-30. PubMed ID: 7723712
    [Abstract] [Full Text] [Related]

  • 15. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart.
    McCully JD, Uematsu M, Parker RA, Levitsky S.
    J Thorac Cardiovasc Surg; 1998 Jul 01; 116(1):154-62. PubMed ID: 9671910
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of time interval between two balloon inflations on ischemic preconditioning during coronary angioplasty.
    Tanaka T, Oka Y, Tawara I, Sada T, Kira Y.
    Cathet Cardiovasc Diagn; 1997 Nov 01; 42(3):263-7. PubMed ID: 9367098
    [Abstract] [Full Text] [Related]

  • 19. Intracoronary-administered urapidil does not influence myocardial contractility, metabolic activity, or coronary sinus blood flow in humans.
    van der Stroom JG, van Wezel HB, Piek JJ, Kal JE, van der Linden R, Vergroesen I, Pfaffendorf M, van Zwieten PA.
    J Cardiothorac Vasc Anesth; 1999 Dec 01; 13(6):684-9. PubMed ID: 10622649
    [Abstract] [Full Text] [Related]

  • 20. Maximal myocardial perfusion by videodensitometry in the assessment of the early and late results of coronary angioplasty: relationship with coronary artery measurements and left ventricular function at rest.
    Vassanelli C, Menegatti G, Molinari J, Zanotto G, Zanolla L, Loschiavo I, Zardini P.
    Cathet Cardiovasc Diagn; 1995 Apr 01; 34(4):301-10; discussion 311-2. PubMed ID: 7621539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.